-
1.1,2-benzoisoxazole derivative or its salt and brain-protecting agent comprising the same 失效
标题翻译: 1,2-苯并异恶唑衍生物或其盐和包含其的脑保护剂公开(公告)号:US5578627A
公开(公告)日:1996-11-26
申请号:US411667
申请日:1995-04-12
申请人: Kenji Takeda , Nobuo Terashima , Joji Nakano , Hisashi Minami , Toyokazu Kobayashi , Kunikazu Furuhata , Tadakazu Takakura , Makoto Takata , Hiroyo Kawafuchi , Toru Hiraiwa
发明人: Kenji Takeda , Nobuo Terashima , Joji Nakano , Hisashi Minami , Toyokazu Kobayashi , Kunikazu Furuhata , Tadakazu Takakura , Makoto Takata , Hiroyo Kawafuchi , Toru Hiraiwa
IPC分类号: C07D261/20 , C07D413/04 , C07D413/12 , C07D413/14 , C07D417/12 , A61K31/405 , C07D209/10
CPC分类号: C07D413/04 , C07D261/20 , C07D413/12 , C07D413/14 , C07D417/12
摘要: This invention relates to a 1,2-benzoisoxazole derivative represented by the following general formula (I) or its salt: ##STR1##
摘要翻译: PCT No.PCT / JP93 / 01549 Sec。 371日期:1995年4月12日 102(e)日期1995年4月12日PCT 1993年10月27日PCT公布。 出版物WO94 / 10158 日期:1994年5月11日本发明涉及由以下通式(I)表示的1,2-苯并异恶唑衍生物或其盐:
-
2.Piperazine derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient 失效
标题翻译: 哌嗪衍生物或其盐,其制备方法和包含其作为活性成分的药物组合物公开(公告)号:US4948796A
公开(公告)日:1990-08-14
申请号:US316174
申请日:1989-02-27
申请人: Toru Hiraiwa , Kenji Takeda , Joji Nakano , Mineichi Sudani , Kunikazu Furuhata , Makoto Takata , Hiroyo Kawafuchi , Isao Watanabe
发明人: Toru Hiraiwa , Kenji Takeda , Joji Nakano , Mineichi Sudani , Kunikazu Furuhata , Makoto Takata , Hiroyo Kawafuchi , Isao Watanabe
IPC分类号: A61K31/00 , A61K31/495 , A61P9/00 , A61P9/08 , C07D20060101 , C07D207/26 , C07D207/27 , C07D213/26 , C07D215/12 , C07D221/16 , C07D233/54 , C07D235/08 , C07D271/10 , C07D271/12 , C07D295/04 , C07D295/06 , C07D295/073 , C07D295/096 , C07D295/135 , C07D295/155 , C07D313/12 , C07D333/54 , C07D337/12 , C07D401/00 , C07D401/12 , C07D403/06 , C07D405/00 , C07D405/12 , C07D409/00 , C07D409/12 , C07D411/12 , C07D413/12 , C07D417/00 , C07D417/12 , C07D491/04 , C07D491/044 , C07D491/052 , C07D491/14 , C07D495/04 , C07D495/14 , C07D521/00 , C07F7/18
CPC分类号: C07D207/27 , C07D213/26 , C07D215/12 , C07D221/16 , C07D231/12 , C07D233/56 , C07D233/64 , C07D235/08 , C07D249/08 , C07D271/10 , C07D271/12 , C07D295/073 , C07D295/096 , C07D295/135 , C07D295/155 , C07D313/12 , C07D333/54 , C07D337/12 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07D491/04 , C07D495/04 , C07F7/1856
摘要: A piperazine derivative represented by the following formula or a salt thereof: ##STR1## which is useful for curing cerebro-vascular disease and post-cerebro-vascular disease.
摘要翻译: 由下式表示的哌嗪衍生物或其盐:
,其可用于治疗脑血管疾病和脑血管疾病。 -
3.Vasodilating and platelet aggregation inhibiting 1,4 dihydropyridines with an imidazolyl or pyridyl containing ester 失效
标题翻译: 血管扩张和血小板聚集抑制1,4-二氢吡啶与咪唑基或含吡啶基酯公开(公告)号:US4713387A
公开(公告)日:1987-12-15
申请号:US747305
申请日:1985-06-21
申请人: Isao Watanabe , Kaishu Momonoi , Toru Hiraiwa , Satoshi Ono , Joji Nakano , Katsuyuki Nagumo , Hiroyasu Takagi
发明人: Isao Watanabe , Kaishu Momonoi , Toru Hiraiwa , Satoshi Ono , Joji Nakano , Katsuyuki Nagumo , Hiroyasu Takagi
IPC分类号: C07D211/90 , C07D213/30 , C07D213/32 , C07D213/38 , C07D213/48 , C07D309/12 , C07D401/12 , C07D405/06 , C07D405/12 , C07D409/14 , C07D521/00 , A61K31/455 , C07D401/10 , C07D401/14
CPC分类号: C07D213/30 , C07D211/90 , C07D213/32 , C07D213/38 , C07D213/48 , C07D231/12 , C07D233/56 , C07D249/08 , C07D309/12 , C07D401/12 , C07D405/06 , C07D405/12 , C07D409/14
摘要: This invention relates to a 1,4-dihydropyridine derivative of the formula ##STR1## wherein Y represents an oxygen or sulfur atom or a vinylene group, Z represents an oxygen or sulfur atom or an alkylene group, R.sup.2 represents an imidazolyl or pyridyl group and the remaining substituents are herein defined. These compounds have a vasodilating activity and a platelet aggregation inhibiting activity.
摘要翻译: 本发明涉及下式所示的1,4-二氢吡啶衍生物,其中Y代表氧或硫原子或亚乙烯基,Z代表氧或硫原子或亚烷基,R2代表咪唑基或吡啶基, 本文定义了其余的取代基。 这些化合物具有血管扩张活性和血小板聚集抑制活性。
-
4.Pyridyl ester containing 1,4-dihydropyridine derivatives and salts thereof and pharmaceutical composition containing the same 失效
标题翻译: 含有1,4-二氢吡啶衍生物及其盐的吡啶基酯和含有它们的药物组合物公开(公告)号:US4731370A
公开(公告)日:1988-03-15
申请号:US872408
申请日:1986-06-10
申请人: Isao Watanabe , Kaishu Momonoi , Toru Hiraiwa , Satoshi Ono , Joji Nakano , Katsuyuki Nagumo , Hiroyasu Takagi
发明人: Isao Watanabe , Kaishu Momonoi , Toru Hiraiwa , Satoshi Ono , Joji Nakano , Katsuyuki Nagumo , Hiroyasu Takagi
IPC分类号: C07D211/90 , C07D213/30 , C07D213/32 , C07D213/38 , C07D213/48 , C07D309/12 , C07D401/12 , C07D405/06 , C07D405/12 , C07D409/14 , C07D521/00 , A61K31/455
CPC分类号: C07D213/30 , C07D211/90 , C07D213/32 , C07D213/38 , C07D213/48 , C07D231/12 , C07D233/56 , C07D249/08 , C07D309/12 , C07D401/12 , C07D405/06 , C07D405/12 , C07D409/14
摘要: This invention relates to a novel 1,4-dihydropyridine derivative of the formula ##STR1## wherein R2 is pyridyl, or a salt thereof. These compounds have a vasodilating activity and a platelet aggregation inhibiting activity. Also disclosed are pharmaceutical compositions containing the same.
摘要翻译: 本发明涉及新的式(Ⅰ)的1,4-二氢吡啶衍生物,其中R2是吡啶基,或其盐。 这些化合物具有血管扩张活性和血小板聚集抑制活性。 还公开了含有该组合物的药物组合物。
-
5.5-Fluoro-(.beta.-uridine or 2'-deoxy-.beta.-uridine) derivatives, a process for producing the same and a carcinostatic agent containing the same 失效
标题翻译: 5-氟 - (β-尿苷或2'-脱氧-β-尿苷)衍生物,其制备方法和含有它们的制癌剂公开(公告)号:US4472386A
公开(公告)日:1984-09-18
申请号:US46109
申请日:1979-06-06
申请人: Tsutomu Kodama , Masaakira Senoura , Hajime Aoyama , Tomonobu Yamaguchi , Isao Kitayama , Minako Yotsuji , Toru Hiraiwa , Masaharu Omori , Nobuo Terashima , Yutaka Kodama
发明人: Tsutomu Kodama , Masaakira Senoura , Hajime Aoyama , Tomonobu Yamaguchi , Isao Kitayama , Minako Yotsuji , Toru Hiraiwa , Masaharu Omori , Nobuo Terashima , Yutaka Kodama
IPC分类号: A61K31/70 , A61K31/7042 , A61K31/7052 , A61K31/7064 , A61K31/7072 , A61P35/00 , C07H19/06 , C07H19/073 , C07H19/08
CPC分类号: C07H19/06
摘要: 5-Fluoro-(.beta.-uridine or 2'-deoxy-.beta.-uridine) derivatives having an acyl group at the 3-position of the molecule. These compounds are useful as carcinostatic agent. This disclosure relates to such compounds, a process for producing the same and a carcinostatic agent comprising such a compound.
摘要翻译: 在分子的3位具有酰基的5-氟 - (β-尿苷或2'-脱氧-β-尿苷)衍生物。 这些化合物可用作制癌剂。 本公开涉及这样的化合物,其制备方法和包含这种化合物的制癌剂。
-
-
-
-